BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16938020)

  • 1. The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease.
    Slabosz A; Lewis SJ; Smigasiewicz K; Szymura B; Barker RA; Owen AM
    Neuropsychology; 2006 Sep; 20(5):578-88. PubMed ID: 16938020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying attentional set-shifting in Parkinson's disease.
    Gauntlett-Gilbert J; Roberts RC; Brown VJ
    Neuropsychologia; 1999 May; 37(5):605-16. PubMed ID: 10340319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.
    Owen AM; Roberts AC; Hodges JR; Summers BA; Polkey CE; Robbins TW
    Brain; 1993 Oct; 116 ( Pt 5)():1159-75. PubMed ID: 8221053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
    Moustafa AA; Sherman SJ; Frank MJ
    Neuropsychologia; 2008 Nov; 46(13):3144-56. PubMed ID: 18687347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning to be inflexible: Enhanced attentional biases in Parkinson's disease.
    Fallon SJ; Hampshire A; Barker RA; Owen AM
    Cortex; 2016 Sep; 82():24-34. PubMed ID: 27318659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease.
    Fallon SJ; Smulders K; Esselink RA; van de Warrenburg BP; Bloem BR; Cools R
    Neuropsychologia; 2015 Oct; 77():42-51. PubMed ID: 26239947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa and the feedback process on set-shifting in Parkinson's disease.
    Au WL; Zhou J; Palmes P; Sitoh YY; Tan LC; Rajapakse JC
    Hum Brain Mapp; 2012 Jan; 33(1):27-39. PubMed ID: 21438075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.
    Kwak Y; Bohnen NI; Müller ML; Dayalu P; Burke DT; Seidler RD
    Behav Brain Res; 2013 May; 245():128-36. PubMed ID: 23439215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionating the Neurocognitive Mechanisms Underlying Working Memory: Independent Effects of Dopamine and Parkinson's Disease.
    Fallon SJ; Mattiesing RM; Muhammed K; Manohar S; Husain M
    Cereb Cortex; 2017 Dec; 27(12):5727-5738. PubMed ID: 29040416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
    Simioni AC; Dagher A; Fellows LK
    Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
    Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
    Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
    Lange KW; Robbins TW; Marsden CD; James M; Owen AM; Paul GM
    Psychopharmacology (Berl); 1992; 107(2-3):394-404. PubMed ID: 1615139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of sustained attention in patients with Parkinson's disease being treated with dopamine precursors].
    Luque-Moreno C; López-García JC; Díaz-Argandoña E
    Rev Neurol; 2012 Sep; 55(5):257-62. PubMed ID: 22930136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy.
    Marini P; Ramat S; Ginestroni A; Paganini M
    Neurol Sci; 2003 Oct; 24(3):184-5. PubMed ID: 14598078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired problem solving in Parkinson's disease: impact of a set-shifting deficit.
    Cronin-Golomb A; Corkin S; Growdon JH
    Neuropsychologia; 1994 May; 32(5):579-93. PubMed ID: 8084416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a motor task learned on levodopa deteriorates when subsequently practiced off.
    Anderson ED; Horak FB; Lasarev MR; Nutt JG
    Mov Disord; 2014 Jan; 29(1):54-60. PubMed ID: 24132873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
    Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
    Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It's all in the type of the task: Dopamine modulates kinematic patterns during competitive vs. cooperative interaction in Parkinson's disease.
    Straulino E; Scaravilli T; Bulgheroni M; D'Amico E; Castiello U
    Neuropsychologia; 2016 Dec; 93(Pt A):106-115. PubMed ID: 27756693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.